Evidence map›Paper›PMID 40708628›Full record

ArticleOpen forum infectious diseases2025

Meeting Report on an Integrated Research Agenda for Mosquito-Borne Arboviruses.

Angela K Ulrich, Nicolina M Moua, Alison Mack, Natsuko Imai-Eaton, J Erin Staples, Angela J Mehr, Julia T Ostrowsky, Tabitha Leighton, Ana Cehovin, Petra C Fay and 22 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Angela K UlrichCenter for Infectious Disease Research and Policy (CIDRAP), University of Minnesota, Minneapolis, Minnesota, USA.ORCID https://orcid.org/0000-0002-4360-9719
Nicolina M MouaCenter for Infectious Disease Research and Policy (CIDRAP), University of Minnesota, Minneapolis, Minnesota, USA.
Alison MackIndependent Consultant to CIDRAP, Wilmington, Delaware, USA.ORCID https://orcid.org/0009-0001-5454-2409
Natsuko Imai-EatonWellcome Trust, London, UK.ORCID https://orcid.org/0000-0002-4218-9716
J Erin StaplesCenters for Disease Control and Prevention, Fort Collins, Colorado, USA.
Angela J MehrCenter for Infectious Disease Research and Policy (CIDRAP), University of Minnesota, Minneapolis, Minnesota, USA.ORCID https://orcid.org/0009-0004-1885-3279
Julia T OstrowskyCenter for Infectious Disease Research and Policy (CIDRAP), University of Minnesota, Minneapolis, Minnesota, USA.
Tabitha LeightonCenter for Infectious Disease Research and Policy (CIDRAP), University of Minnesota, Minneapolis, Minnesota, USA.
Ana CehovinWellcome Trust, London, UK.ORCID https://orcid.org/0000-0002-5809-122X
Petra C FayWellcome Trust, London, UK.
Josephine P GoldingWellcome Trust, London, UK.
Emma MaynardWellcome Trust, London, UK.
Luke AlpheyDepartment of Biology, University of York, York, UK.ORCID https://orcid.org/0000-0002-2916-3802
Diana P Rojas AlvarezWorld Health Organization, Geneva, Switzerland.ORCID https://orcid.org/0000-0003-0241-6416
Lark L CoffeySchool of Veterinary Medicine, University of California, Davis, Davis, California, USA.ORCID https://orcid.org/0000-0002-0718-5146
Nuno R FariaMRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.ORCID https://orcid.org/0000-0001-8839-2798
Rafael Maciel-de-FreitasFundação Oswaldo Cruz, Rio de Janeiro, Brazil.ORCID https://orcid.org/0000-0002-2198-6492
Kevin MaringerThe Pirbright Institute, Pirbright, UK.ORCID https://orcid.org/0000-0003-0977-8807
Kris A MurrayCentre on Climate Change and Planetary Health, Medical Research Council Unit The Gambia, London School of Hygiene & Tropical Medicine, London, UK.
Henrik SaljeDepartment of Genetics, University of Cambridge, Cambridge, UK.ORCID https://orcid.org/0000-0003-3626-4254
Rosemary SangInternational Centre of Insect Physiology and Ecology, Nairobi, Kenya.
Pedro F C VasconcelosUniversidade do Estado do Pará, Belém, Pará, Brazil.
Yee-Sin LeoNational Healthcare Group, National Centre for Infectious Diseases, Singapore.ORCID https://orcid.org/0000-0003-4978-5825
Steven P SinkinsMedical Research Council (MRC) University of Glasgow Centre for Virus Research, Glasgow, UK.
Jocelyne Neto de VasconcelosCentro de Investigação em Saúde de Angola, Caxito, Angola.ORCID https://orcid.org/0000-0002-7318-693X
Samuel K DadzieNoguchi Memorial Institute for Medical Research, Accra, Ghana.ORCID https://orcid.org/0000-0002-4105-1010
Eva HarrisDivision of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, USA.ORCID https://orcid.org/0000-0002-7238-4037
Thais H Dos SantosPan American Health Organization, Washington, DC, USA.
Raman VelayudhanWorld Health Organization, Geneva, Switzerland.
Jurai WongsawatDepartment of Disease Control, Ministry of Public Health, Bamrasnaradura Infectious Disease Institute, Nonthaburi, Thailand.
Michael T OsterholmCenter for Infectious Disease Research and Policy (CIDRAP), University of Minnesota, Minneapolis, Minnesota, USA.ORCID https://orcid.org/0000-0003-1017-2618
Eve M LackritzCenter for Infectious Disease Research and Policy (CIDRAP), University of Minnesota, Minneapolis, Minnesota, USA.

Funding

World Health Organization 001
6 · The paper itself

Abstract

The emergence and re-emergence of mosquito-borne arbovirus (MBV) diseases pose a rapidly expanding global health threat fueled by the convergence of multiple ecologic, economic, and social factors, including climate change, land use, poverty, deficiencies of water storage and sanitation, and limitations of vector control programs. On December 6, 2023, the Wellcome Trust and the University of Minnesota's Center for Infectious Disease Research and Policy held a meeting titled "An integrated approach to mosquito-borne arboviruses: a priority research agenda." The meeting comprised presentations, panels, and facilitated discussions aimed at describing the state of the field, highlighting recent accomplishments, identifying novel strategies, and defining priority research goals and approaches for addressing MBV disease preparedness and response. This report summarizes meeting discussions in 3 key areas: the changing epidemiology of MBV disease, current and potential transmission- and disease-monitoring strategies, and evolutionary impacts on disease burden and transmission. It concludes with a list of priority strategies for research and investment in MBV disease prevention, preparedness, and control. To prepare for future epidemics of MBV diseases, research and policy will benefit from a multipathogen approach to MBVs. Building on existing knowledge and systems, these efforts must address social and ecological factors and connect with other global health agendas.

Indexed as

disease controldisease preventionmosquito-borne arboviruspolicyresearch

Identifiers

PMID40708628
PMCPMC12287632

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.